文献速递类风湿关节炎

Semaphorin 3B在血清诱导性关节炎模型中的核心作用及类风湿关节炎患者中水平降低

Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2022-04-13

该研究在K/BxN血清转移关节炎模型中比较野生型与Sema3B-/-小鼠,发现Sema3B缺失加重临床严重度并增加炎症介质表达和鼠FLS迁移能力,给予重组Sema3B可减轻严重度。在患者中,已确诊RA的滑膜组织和血清Sema3B显著低于关节痛患者;关节痛后进展为RA者血清Sema3B升高,但RA发病后1年和2年大幅下降。

要点

  • Sema3B-/-小鼠血清诱导性关节炎临床严重度显著高于野生型小鼠。
  • 给予重组鼠Sema3B可降低血清诱导性关节炎的临床严重度和炎症介质表达。
  • 已确诊RA患者滑膜组织和血清Sema3B显著低于关节痛患者,且血清水平随疾病阶段变化。

核心结论

  • Sema3B在小鼠关节炎模型中起保护作用。
  • RA患者血清Sema3B表达水平取决于疾病阶段,提示其在疾病发生和进展中可能有不同调控作用。

研究设计与样本

  • 在K/BxN血清转移关节炎模型中,比较野生型(WT)与Sema3B-/-小鼠的临床反应、组织学特征和FLS功能。
  • 检测小鼠关节和鼠FLS以及关节痛患者和RA患者血清与滑膜组织中Sema3B的蛋白和信使RNA表达。
  • 采用酶联免疫吸附测定、免疫印迹、定量聚合酶链反应和RNA测序检测表达,采用伤口闭合实验测定FLS迁移。

主要发现

  • Sema3B-/-小鼠血清诱导性关节炎的临床严重度显著高于WT小鼠,并伴有炎症介质表达增加和鼠FLS迁移能力增强。
  • 给予重组鼠Sema3B可降低血清诱导性关节炎的临床严重度和炎症介质表达。
  • 已确诊RA患者滑膜组织和血清Sema3B显著低于关节痛患者。
  • 后来进展为RA的关节痛患者血清Sema3B水平升高,而未进展为RA者未升高;但这些水平在RA发病后1年和2年大幅下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Semaphorin 3B (Sema3B) decreases the migratory and invasive capacities of fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) and suppresses expression of matrix metalloproteinases. We undertook this study to examine the role of Sema3B in a mouse model of arthritis and its expression in RA patients. METHODS: Clinical responses, histologic features, and FLS function were examined in wild-type (WT) and Sema3B-/- mice in a K/BxN serum transfer model of arthritis. Protein and messenger RNA expression of Sema3B in mouse joints and murine FLS, as well as in serum and synovial tissue from patients with arthralgia and patients with RA, was determined using enzyme-linked immunosorbent assay, immunoblotting, quantitative polymerase chain reaction, and RNA sequencing. FLS migration was determined using a wound closure assay. RESULTS: The clinical severity of serum-induced arthritis was significantly higher in Sema3B-/- mice compared to WT mice. This was associated with increased expression of inflammatory mediators and increased migratory capacity of murine FLS. Administration of recombinant mouse Sema3B reduced the clinical severity of serum-induced arthritis and the expression of inflammatory mediators. Sema3B expression was significantly lower in the synovial tissue and serum of patients with established RA compared to patients with arthralgia. Serum Sema3B levels were elevated in patients with arthralgia that later progressed to RA, but not in those who did not develop RA; however, these levels drastically decreased 1 and 2 years after RA development. CONCLUSION: Sema3B expression plays a protective role in a mouse model of arthritis. In RA patients, expression levels of Sema3B in the serum depend on the disease stage, suggesting different regulatory roles in disease onset and progression.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Igea A, Carvalheiro T, Malvar-Fernández B, et al. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2022. PMID: 35001548. doi:10.1002/art.42065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。